OUI’s Incubator welcomes a new Cohort of start-up companies into the fold
The Start-up Incubator fosters entrepreneurship skills amongst the University of Oxford's students and staff.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
The Start-up Incubator fosters entrepreneurship skills amongst the University of Oxford's students and staff.
This year, around 100,000 people in the UK will have a stroke. AI algorithms developed by Oxford University spinout Brainomix are ensuring that more of those patients will receive better care and better outcomes.
It’s a tough climate for raising capital - our Oxford spinout companies are working hard to deliver impressive results. The OUI team recently travelled to the JPM Healthcare conference in San Francisco to connect our spinout leaders with US and global life science investors.
OUI’s Diabetes Health Profiles empower those living with diabetes to have a voice in their healthcare.
Oxford University Innovation announces the much-anticipated relaunch of the Oxford Innovation Society (OIS). With an ambitious 12-month programme of events, OIS aims to fortify connections between Oxford’s companies, investors, industry partners and the vibrant Oxford entrepreneurial ecosystem.
Rob McNeil, Oxford University's Migration Observatory, engages in consultancy work facilitated by OUI, supporting journalists and communicators in fostering informed and balanced discussions on migration.
Approximately half of the spinout companies created in Oxford involve software. In response to a recent government-commissioned review calling for specific terms for ventures exclusively focused on software, OUI's Dr Richard Auburn shares his views.
Oxford University Innovation (OUI) welcomes the Independent Review of University Spin-out companies, published today.
For the latest in our CEO Spotlight series, we caught up with Dr Tony Coombs, Executive Chairman of Oxford VacMedix - a spinout company making waves in the world of cancer vaccines with its impressive pre-clinical and Phase 1 trial results.